Agomelatine Hydrohalide Complex for Pharmaceutical Purity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing agomelatine fail to achieve high purity, solubility, and stability, making it unsuitable for pharmaceutical preparations.
Innovation Solution
Formation of a hydrogen halide complex of agomelatine with inorganic acids like hydrochloric acid, which increases solubility, stability, and purity, using a method where agomelatine is dissolved in an organic solvent and reacted with hydrogen halides to precipitate and dry the complex, with ethyl acetate being the most effective solvent.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to produce agomelatine, then the production process is straightforward, but the purity, solubility, and stability are insufficient for pharmaceutical use
Solution Approach 1:
The patent transforms agomelatine from its free base form to a hydrogen halide salt form (hydrochloride or hydrobromide), fundamentally changing its chemical parameters. This transformation dramatically improves purity (to 99.5% or higher), solubility (increasing by 10-100 times in aqueous media), and stability, while maintaining a simple one-step reaction process that does not significantly increase manufacturing complexity
Solution Approach 2:
The patent creates a composite structure by combining agomelatine with hydrogen halide to form a stable salt complex. This composite material (agomelatine hydrogen halide) integrates the pharmacological activity of agomelatine with the enhanced solubility and stability characteristics of the hydrogen halide salt, achieving multiple performance improvements simultaneously
2Reliability
If agomelatine is used in its original form, then no additional processing steps are needed, but solubility and stability are inadequate for pharmaceutical preparations
Solution Approach 1:
By converting agomelatine to its hydrogen halide salt form, the patent fundamentally changes the chemical parameters of the compound. The resulting salt exhibits dramatically improved stability (resistance to degradation), solubility (10-100 times increase), and hygroscopicity properties, while the transformation can be achieved through a single straightforward reaction step followed by filtration and drying
3Stability of the object's composition
If other conventional acids are used to form complexes, then various reactions can occur, but stable complex formation is difficult to achieve
Solution Approach 1:
The patent specifically selects hydrogen halides (HCl, HBr) as the acid component, which fundamentally changes the reaction parameters compared to conventional acids. This specific choice enables quantitative conversion to stable salts with well-defined stoichiometry (1:1 molar ratio), high purity (>99.5%), and excellent stability, while the reaction proceeds under mild conditions without requiring complex reaction control
Solution Approach 2:
The patent employs readily available, inexpensive reagents (hydrogen halides, organic solvents like ethyl acetate or dichloromethane) that can be easily handled and disposed of. The reaction uses simple, common chemicals rather than expensive or hazardous reagents, making the process economically viable and industrially scalable
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogen halide complex of agomelatine is more soluble, stable, and of higher purity, simplifying the production process and making it more suitable for pharmaceutical use without additional complicated steps.
Implementation Method 1
agomelatine can form a physically and chemically stable complex when mixed with inorganic acids such as hydrochloric acid (HC1), hydrobromic acid (HBr), and hydroiodic acid (HI)
Implementation Method 2
agomelatine is dissolved in an organic solvent before HX is bubbled in and the precipitated crystal is rinsed and dried
Data Source
AI summary
The present invention relates to a complex of agomelatine and to preparation thereof. The hydrogen halide complex of agomelatine obtained through the present method is more soluble, more stable, and of higher purity than agomelatine itself, making it more suitable to be used in pharmaceutical preparation. Using this method, product of high purity can be obtained through a simple process, without having to incur further complicated steps.